
Cellino
@cellinobio
Building an ultra-scalable biomanufacturing technology stack for personalized cell and tissue replacement therapies.
ID: 938800346683592704
http://www.cellinobio.com 07-12-2017 16:00:19
778 Tweet
1,1K Followers
318 Following


Check out the latest blog from our Co-Founder & Chief Product Officer Marinna Madrid, who led the strategy that secured the U.S. FDA Advanced Manufacturing Technology designation—recognizing Cellino's innovation in #regenmed manufacturing. 📖 Read it here: linkedin.com/pulse/from-inv…


Regulatory recognition invites reflection—not just on the science, but on the journey behind it. In this video, Marinna Madrid shares her path as a founder and regulatory leader, and what the FDA’s AMT designation means for the future of #regenmed. 🎥⬇️ vimeo.com/1088041888?sha…



🚀 If you’re in #Boston next week for #BIO2025, we’re looking forward to seeing you there! Join our Co-Founders, CEO Nabiha Saklayen and Chief Product Officer @MarinnaMadrid, as they speak on early-stage #investment, advanced #biomanufacturing, and expanding #healthequity.


It’s been an exhilarating week in #Boston at #BIO25! We’re honored to have our Co-Founders, CEO Nabiha Saklayen and Chief Product Officer Marinna Madrid, share how we’re accelerating the development of personalized #regenmed and building toward a future of #healthequity. Thank you to


📢 Excited to share Willie Reaves, our Head of Public Engagement, is a keynote speaker at AI for Good 🇺🇳 #AIforGood in #Geneva on July 9! Join us for his session on #AI-driven #biomanufacturing & the future of personalized #regenmed. #AIforGood 🔗See details: aiforgood.itu.int/summit-2025



🚀Join us in #Japan for Keio University’s 8th Regeneration & Drug Discovery Seminar on Aug 4! Marinna Madrid will speak on “Autonomous Biomanufacturing of #iPSC-Based Cell Therapies” and share our vision for a more scalable future in #healthcare. 📧 Questions or RSVP requests:


📢 Marinna Madrid will speak at @cira_ku_e’s Seminar Series on August 8 from 4:00 to 5:00 PM JST at Kyoto_News! She’ll present Nebula, our #AI-driven platform for scalable production of #iPSC-derived therapies. 📧 Register: [email protected]





📢 Honored to announce that our Co-Founder & CEO, Nabiha Saklayen, will be co-chairing the NASEM Health’s “Developing Regenerative Medicine Therapies with #AI” workshop on Nov 18 in #DC. 👉 Join us in person or online: bit.ly/4n2GP6s


Think of your body as the greatest artwork ever created. Each cell is a brushstroke. Today our Co-Founder & CPO Marinna Madrid is launching her Substack, starting with how iPSCs let us rewind biology’s brushstrokes!🎨 Take a peek → substack.com/@biophysica/p-…


👏 Congratulations to our Founder & CEO, Nabiha Saklayen named a 2025 @BioSpace 40 Under 40 honoree for #innovation and #patientimpact in #biotech! See the full list ➡️ bit.ly/4o5FegH
